Tech Company Financing Transactions
Mithridion Funding Round
Mithridion closed a $1.3 million financing round on 1/11/2011. Investors included Rocket Ventures and Venture Investors.
Transaction Overview
Company Name
Announced On
1/11/2011
Transaction Type
Venture Equity
Amount
$1,250,000
Round
Undisclosed
Investors
Venture Investors (John Neis)
Proceeds Purpose
Mithridion intends to develop its drug candidates for AD and schizophrenia in partnership with pharmaceutical or biopharmaceutical companies with the technical, manufacturing and commercial resources to address these major market opportunities.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
505 Science Drive C
Madison, WI 53511
USA
Madison, WI 53511
USA
Phone
Website
Email Address
Overview
Mithridion is a biopharmaceutical company that discovers and develops drugs for neurodegenerative diseases, with a focus on Alzheimer's disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Trevor Twose
Browse more venture capital transactions:
Prev: 1/11/2011: Bump venture capital transaction
Next: 1/11/2011: WorkFusion venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs